This article refers to:
Nandlal L, Perumal R, Naidoo K. Infect Drug Resist. 2022;15:4971–4984.
Table 2 Performance of WHO-Endorsed Molecular Diagnostics for Drug-Resistant TB Diagnosis and Drug-Susceptibility Testing
The authors have advised that there is an error in Table 2 on pages 4975 and 4976. The text “$1240” in the Cost Per Test column for the TRUENAT MTB-RIF Dx (Molbio) 2020 row should read “$12.40”.
This error was introduced by the Editorial staff during the publication process. The correct Table 2 is shown below.